PhaseBio Pharmaceuticals (PHAS) null Earnings

19OctConfirmed
Aug 18
Oct 18
-10.45
-6.97
-3.48
0

Details

Expected EPS
-0.48
Actual EPS
-10.45
Surprise EPS
-9.97
Surprise Percent
+2,077.08%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -10.45 per share for .

0 Comments

Share your thoughts